Pulmonary rehabilitation for COPD and other lung diseases
Concurrent treatment with ø-agonists and/or hormonal treatments and/or new therapies (e.g., spiriva) and/or concurrent treatment with supplementary oxygen6. Concurrent PR in disease management programs7. Place of delivery (e.g., home, inpatient, outpatient).8. Physician supervision9. Components of t...
| Main Authors: | , , , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, Maryland
AHRQ Technology Assessment Program
2006, November 21, 2006
|
| Series: | Technology assessment
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references